· Periodic Report
Q3 revenue KRW 13.4 billion, operating loss KRW 1.3 billion
In Q3, Engenbio sold KRW 13.4 billion worth and lost KRW 1.3 billion from its main business; sales rose 147.5% from a year earlier and 7.9% from the prior quarter.
NGeneBio Co., Ltd. Disclosures
354200 · KOSDAQ · Based on DART filings
Disclosures
1 total · 20 per page
Catch the next disclosure fast
Get app alerts for new disclosures from NGeneBio Co., Ltd..